Nkarta Inc (NKTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.62
• Market Cap: $183.97M
• EPS: $-1.38
• 52-Week High: $2.74
• 52-Week Low: $1.31

About Nkarta Inc

Nkarta, Inc. is a clinical-stage biopharmaceutical company located in South San Francisco, California, dedicated to pioneering advanced cell therapies for the treatment of cancer. Utilizing its proprietary technology platform, Nkarta is developing innovative therapies that leverage the immune system to effectively target and eradicate cancer cells. The company boasts a strong pipeline of product candidates in multiple clinical development phases, positioning itself as a key player in addressi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Nkarta Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NKTX pay dividends?

Nkarta Inc (NKTX) does not currently pay a regular dividend.

What is NKTX's market cap?

Nkarta Inc (NKTX) has a market capitalization of $183.97M with a current stock price of $2.62.